Apyx Medical (APYX) Liabilities from Discontinued Operations (2017)

Apyx Medical (APYX) posted Liabilities from Discontinued Operations of 2248000.0 for Q4 2017.

Apyx Medical (APYX) Liabilities from Discontinued Operations (2017) Analysis & Trends

Apyx Medical's Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 2248000.0 for Q4 2017.

Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 2248000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 2248000.0 (changed N/A YoY) and the FY2017 annual result came in at 2248000.0, changed N/A from the prior year.
Liabilities from Discontinued Operations was 2248000.0 for Q4 2017 at Apyx Medical.
Across five years, Liabilities from Discontinued Operations topped out at 2248000.0 in Q4 2017 and bottomed at 2248000.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	180.89 Bn	173.59 Bn	6.27 Bn
2	Stryker	127.82 Bn	124.94 Bn	3.81 Bn
3	Medtronic	107.49 Bn	98.27 Bn	6.41 Bn
4	Boston Scientific	67.24 Bn	65.78 Bn	3.61 Bn
5	Edwards Lifesciences	48.02 Bn	44.34 Bn	1.29 Bn
6	Dexcom	28.25 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	28.17 Bn	25.89 Bn	1.98 Bn
8	Smith & Nephew	26.72 Bn	26.14 Bn	-
9	Koninklijke Philips	25.31 Bn	22.19 Bn	2.07 Bn
10	Apyx Medical	173.66 Mn	142.52 Mn	7.93 Mn

Download Data

Date	Value
Dec 31, 2017	2.25 Mn
Dec 31, 2017	2.25 Mn